FI961564A0 - Imidatso(1,2-a)pyridiinien alkoksialkyylikarbamaatit - Google Patents

Imidatso(1,2-a)pyridiinien alkoksialkyylikarbamaatit

Info

Publication number
FI961564A0
FI961564A0 FI961564A FI961564A FI961564A0 FI 961564 A0 FI961564 A0 FI 961564A0 FI 961564 A FI961564 A FI 961564A FI 961564 A FI961564 A FI 961564A FI 961564 A0 FI961564 A0 FI 961564A0
Authority
FI
Finland
Prior art keywords
pct
alkoxyalkylcarbamates
pyridines
imidazo
sec
Prior art date
Application number
FI961564A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI961564L (fi
FI961564A7 (fi
Inventor
Joerg Sennbilfinger
Gerhard Grundler
Richard Riedel
Stefan Postius
Wolfgang-Alexander Simon
Georg Rainer
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of FI961564L publication Critical patent/FI961564L/fi
Publication of FI961564A7 publication Critical patent/FI961564A7/fi
Publication of FI961564A0 publication Critical patent/FI961564A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Luminescent Compositions (AREA)
FI961564A 1993-10-11 1994-10-08 Imidatso(1,2-a)pyridiinien alkoksialkyylikarbamaatit FI961564A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH304793 1993-10-11
PCT/EP1994/003326 WO1995010518A1 (de) 1993-10-11 1994-10-08 ALKOXYALKYLCARBAMATE VON IMIDAZO(1,2-a)PYRIDINEN

Publications (3)

Publication Number Publication Date
FI961564L FI961564L (fi) 1996-04-10
FI961564A7 FI961564A7 (fi) 1996-04-10
FI961564A0 true FI961564A0 (fi) 1996-04-10

Family

ID=4247423

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961564A FI961564A0 (fi) 1993-10-11 1994-10-08 Imidatso(1,2-a)pyridiinien alkoksialkyylikarbamaatit

Country Status (26)

Country Link
US (1) US5719161A (cs)
EP (1) EP0723544B1 (cs)
JP (1) JP3526305B2 (cs)
KR (1) KR100339059B1 (cs)
CN (1) CN1042633C (cs)
AT (1) ATE200672T1 (cs)
AU (1) AU685176B2 (cs)
BG (1) BG100459A (cs)
CA (1) CA2173876C (cs)
CZ (1) CZ290325B6 (cs)
DE (1) DE59409735D1 (cs)
DK (1) DK0723544T3 (cs)
EE (1) EE03262B1 (cs)
ES (1) ES2157992T3 (cs)
FI (1) FI961564A0 (cs)
GR (1) GR3035943T3 (cs)
HU (1) HU220066B (cs)
NO (1) NO305864B1 (cs)
NZ (1) NZ275419A (cs)
PL (1) PL176424B1 (cs)
PT (1) PT723544E (cs)
RO (1) RO118428B1 (cs)
RU (1) RU2139288C1 (cs)
SK (1) SK283264B6 (cs)
UA (1) UA48122C2 (cs)
WO (1) WO1995010518A1 (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2196078A1 (en) * 1994-07-28 1996-02-08 Gerhard Grundler Imidazopyridine-azolidinones
DE19602855A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chem Fab Neue 3-Methylimidazopyridine
CA2244770A1 (en) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chemische Fabrik Gmbh 3-methylimidazopyridines
AU1545297A (en) * 1996-01-26 1997-08-20 Byk Gulden Imidazopyridine halides
SE9802794D0 (sv) 1998-08-21 1998-08-21 Astra Ab New compounds
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
RS52908B (en) 2003-03-10 2014-02-28 Takeda Gmbh NEW PROCEDURE FOR OBTAINING ROFLUMILAST
US20080280944A1 (en) 2003-11-03 2008-11-13 Paula Fernstrom Imidazo[1,2-A]Pyridine Derivatives For The Treatment Of Silent Gastro-Esophageal Reflux
JP5383183B2 (ja) * 2005-03-16 2014-01-08 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング ロフルミラストを含有する矯味された剤形

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU117992A1 (ru) * 1958-04-11 1958-11-30 Н.В. Олехнович Устройство дл отсчета и записи на рассто нии показаний стрелочных приборов
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
EP0266890A1 (en) * 1986-10-07 1988-05-11 Yamanouchi Pharmaceutical Co. Ltd. Imidazopyridine derivatives, their production, and pharmaceutical compositions containing them
US4831041A (en) * 1986-11-26 1989-05-16 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
JPH02270873A (ja) * 1989-03-13 1990-11-05 Fujisawa Pharmaceut Co Ltd イミダゾピリジン化合物およびその製造法

Also Published As

Publication number Publication date
SK45096A3 (en) 1997-01-08
PL313941A1 (en) 1996-08-05
CZ105596A3 (en) 1996-06-12
EE03262B1 (et) 2000-04-17
CA2173876A1 (en) 1995-04-20
AU7937294A (en) 1995-05-04
EP0723544A1 (de) 1996-07-31
RU2139288C1 (ru) 1999-10-10
SK283264B6 (sk) 2003-04-01
NO305864B1 (no) 1999-08-09
WO1995010518A1 (de) 1995-04-20
FI961564L (fi) 1996-04-10
CN1042633C (zh) 1999-03-24
FI961564A7 (fi) 1996-04-10
CZ290325B6 (cs) 2002-07-17
DK0723544T3 (da) 2001-08-06
HU9600890D0 (en) 1996-06-28
HU220066B (hu) 2001-10-28
AU685176B2 (en) 1998-01-15
UA48122C2 (uk) 2002-08-15
NZ275419A (en) 1996-12-20
ATE200672T1 (de) 2001-05-15
CN1134702A (zh) 1996-10-30
ES2157992T3 (es) 2001-09-01
CA2173876C (en) 2005-09-27
BG100459A (bg) 1996-11-29
KR960704890A (ko) 1996-10-09
RO118428B1 (ro) 2003-05-30
DE59409735D1 (de) 2001-05-23
NO961414L (no) 1996-06-10
PT723544E (pt) 2001-09-28
PL176424B1 (pl) 1999-05-31
HUT73851A (en) 1996-09-30
EP0723544B1 (de) 2001-04-18
GR3035943T3 (en) 2001-08-31
JPH09503515A (ja) 1997-04-08
US5719161A (en) 1998-02-17
KR100339059B1 (ko) 2002-11-23
HK1011681A1 (en) 1999-07-16
NO961414D0 (no) 1996-04-10
JP3526305B2 (ja) 2004-05-10

Similar Documents

Publication Publication Date Title
FI961564A0 (fi) Imidatso(1,2-a)pyridiinien alkoksialkyylikarbamaatit
ATE192151T1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
DK0672041T3 (da) Farmakologisk aktive pyridinderivater og fremgangsmåder til fremstilling deraf
DE122010000050I2 (de) Sublinguales oder bukkales arzneimittel.
MX9604378A (es) Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios.
DE69507029D1 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten
AU2672995A (en) {a}-annelated pyrrole derivatives and pharmaceutical uses thereof
GB9418912D0 (en) Pharmaceutically active compounds
NO306400B1 (no) N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat
ATE143947T1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
ATE143946T1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
EE03123B1 (et) Kinoliini derivaadid, nende valmistamise protsess, neid sisaldavad ravimpreparaadid ja nende kasutamine
ATE190845T1 (de) Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen
ES2123836T3 (es) Imidazo(1,5-a)quinoleinas para el tratamiento de la ansiedad y trastornos del sueño.
ATE221068T1 (de) Anellierte beta-carboline